Dermatology Research and Education Foundation

Recent papers from Dermatology Research and Education Foundation

1. Initiating Biologics in Atopic Dermatitis: Global Practices and Recommendations from the AMAZE ProjectDermatology and Therapy · 2026
2. A Scoping Review of Prosocial and Antisocial Media Content and Effects in Narrative Entertainment Research Across Five DecadesCommunication Research · 2025
3. Approaching or avoiding? Gender asymmetry in reactions to prior job search outcomes by gig workers in female- versus male-typed job domainsSocial Forces · 2025
4. Predicting discontinuation of biologic therapy caused by adverse events in psoriasis patients—A Danish nationwide cohort studyJEADV Clinical Practice · 2023
5. Ability of lactulose breath test results to accurately identify colorectal polyps through the measurement of small intestine bacterial overgrowthWorld Journal of Gastrointestinal Surgery · 2023
6. Drug Survival of Adalimumab, Secukinumab, and Ustekinumab in Psoriasis as Determined by Either Dose Escalation or Drug Discontinuation during the First 3 Years of Treatment – a Nationwide Cohort StudyJournal of Investigative Dermatology · 2023
7. Adverse childhood experiences and depressive symptoms among adolescents during the COVID-19 pandemic: mediating roles of poor sleep quality and psychological inflexibilityPsychology Health & Medicine · 2023
8. The Association between Fatigue and Adult Atopic Dermatitis: A Cross-Sectional StudyDermatitis · 2023
9. The Integrated 31-Gene Expression Profile Test (i31-GEP) for Cutaneous Melanoma Outperforms the CP-GEP at Identifying Patients who can Forego Sentinel Lymph Node Biopsy when Applying NCCN GuidelinesSKIN The Journal of Cutaneous Medicine · 2022
10. Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual LevelJAMA Dermatology · 2022
11. Real-World Effectiveness of Newly Initiated Systemic Therapy for Atopic Dermatitis in the United States: A Claims Database AnalysisAdvances in Therapy · 2022
12. The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization studyBritish Journal of Dermatology · 2022
13. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasisJournal of the European Academy of Dermatology and Venereology · 2022
14. Incidence, prevalence and risk of acne in adolescent and adult patients with atopic dermatitis: a matched cohort studyJournal of the European Academy of Dermatology and Venereology · 2022
15. Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV TrialCureus · 2021
16. Drug Survival of Biologics in Patients With Hidradenitis SuppurativaJAMA Dermatology · 2021
17. Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic DermatitisDermatology and Therapy · 2021
18. Long‐term safety of risankizumab from 17 clinical trials in patients with moderate‐to‐severe plaque psoriasis*British Journal of Dermatology · 2021
19. Gene expression in Lucilia sericata ( Diptera : Calliphoridae ) larvae exposed to Pseudomonas aeruginosa and Acinetobacter baumannii identifies shared and microbe‐specific induction of immune genesInsect Molecular Biology · 2021
20. Biologics update: IL‐17 inhibitorsDermatological Reviews · 2021